Assad Sattar
Interventional Cardiology · Dearborn, MINPI 1154554590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $719 and has fallen 69.4% since, to $220 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MI, where the typical reported total is $6,857.
Across 115 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$578
- Novartis$412
- Abbott$277
- Cordis US CORP.$247
- Boston Scientific$205
- Amgen$132
- plus $883 from 16 others
What the payments were for
- Food & beverage$2,71999%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 17 | $578 |
| Novartis | 24 | $412 |
| Abbott | 11 | $277 |
| Cordis US CORP. | 12 | $247 |
| Boston Scientific | 10 | $205 |
| Amgen | 5 | $132 |
| Kestra Medical Technology Services, Inc. | 1 | $119 |
| Bard Peripheral Vascular, Inc. | 3 | $107 |
| E.r. Squibb & Sons, L.L.C. | 2 | $103 |
| AstraZeneca | 6 | $88 |
| Merck | 4 | $87 |
| Philips North America LLC | 3 | $74 |
| Johnson & Johnson | 4 | $70 |
| Boehringer Ingelheim | 3 | $56 |
| Preventice Services, LLC | 2 | $52 |
| Amarin Pharma, Inc. | 2 | $24 |
| Medtronic | 1 | $24 |
| Edwards Lifesciences | 1 | $20 |
| Bayer | 1 | $17 |
| Pfizer | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Assure WCD$119
How this compares
$2,733 in reported general payments places this provider in the 25th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Dearborn
- Ashok KondurDearborn$38K
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
- Mir BasirDetroit$442K
- Amr AbbasBerkley$416K
- Safwan KassasSaginaw$340K
- Vishal GuptaKalamazoo$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.